{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:45:41Z","timestamp":1793036741056,"version":"4.5.0"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To determine whether empirical antibiotic initiation and selection for children with pneumonia was associated with procalcitonin (PCT) levels when results were blinded to clinicians.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We enrolled children &amp;lt;18 years with radiographically confirmed pneumonia at 2 children\u2019s hospitals from 2014 to 2019. Blood for PCT was collected at enrollment (blinded to clinicians). We modeled associations between PCT and (1) antibiotic initiation and (2) antibiotic selection (narrow versus broad-spectrum) using multivariable logistic regression models. To quantify potential stewardship opportunities, we calculated proportions of noncritically ill children receiving antibiotics who also had a low likelihood of bacterial etiology (PCT &amp;lt;0.25 ng\/mL) and those receiving broad-spectrum therapy, regardless of PCT level.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We enrolled 488 children (median PCT, 0.37 ng\/mL; interquartile range [IQR], 0.11\u20132.38); 85 (17%) received no antibiotics (median PCT, 0.32; IQR, 0.09\u20131.33). Among the 403 children receiving antibiotics, 95 (24%) received narrow-spectrum therapy (median PCT, 0.24; IQR, 0.08\u20132.52) and 308 (76%) received broad-spectrum (median PCT, 0.46; IQR, 0.12\u20132.83). In adjusted analyses, PCT values were not associated with antibiotic initiation (odds ratio [OR], 1.02, 95% confidence interval [CI], 0.97%\u20131.06%) or empirical antibiotic selection (OR 1.07; 95% CI, 0.97%\u20131.17%). Of those with noncritical illness, 246 (69%) were identified as potential targets for antibiotic stewardship interventions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSION<\/jats:title>\n                  <jats:p>Neither antibiotic initiation nor empirical antibiotic selection were associated with PCT values. Whereas other factors may inform antibiotic treatment decisions, the observed discordance between objective likelihood of bacterial etiology and antibiotic use suggests important opportunities for stewardship.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2021-006510","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T08:05:36Z","timestamp":1647849936000},"page":"384-391","source":"Crossref","is-referenced-by-count":4,"title":["Association Between Procalcitonin and Antibiotics in Children With Community-Acquired Pneumonia"],"prefix":"10.1542","volume":"12","author":[{"given":"Mert","family":"Sekmen","sequence":"first","affiliation":[{"name":"aDepartments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakobi","family":"Johnson","sequence":"additional","affiliation":[{"name":"aDepartments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhu","sequence":"additional","affiliation":[{"name":"bBiostatistics, Vanderbilt University School of Medicine, Nashville Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura F.","family":"Sartori","sequence":"additional","affiliation":[{"name":"aDepartments of Pediatrics"},{"name":"eDepartment of Emergency Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[{"name":"cDepartment of Health Policy, Vanderbilt University Medical Center; Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Stassun","sequence":"additional","affiliation":[{"name":"aDepartments of Pediatrics"},{"name":"cDepartment of Health Policy, Vanderbilt University Medical Center; Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald H.","family":"Arnold","sequence":"additional","affiliation":[{"name":"cDepartment of Health Policy, Vanderbilt University Medical Center; Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krow","family":"Ampofo","sequence":"additional","affiliation":[{"name":"dDepartment of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Robison","sequence":"additional","affiliation":[{"name":"dDepartment of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per H.","family":"Gesteland","sequence":"additional","affiliation":[{"name":"dDepartment of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Pavia","sequence":"additional","affiliation":[{"name":"dDepartment of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Williams","sequence":"additional","affiliation":[{"name":"aDepartments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"issue":"6","key":"2022040102575286100_b1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6506a1","article-title":"Core elements of outpatient antibiotic stewardship","volume":"65","author":"Sanchez","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"2022040102575286100_b2","article-title":"Most frequent conditions in US hospitals, 2011: Statistical Brief #162","volume-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Pfuntner","year":"2006"},{"issue":"12","key":"2022040102575286100_b3","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/673982","article-title":"Identifying targets for antimicrobial stewardship in children\u2019s hospitals","volume":"34","author":"Gerber","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"2022040102575286100_b4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"2022040102575286100_b5","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1093\/cid\/cir048","article-title":"Interpreting assays for the detection of Streptococcus pneumoniae","volume":"52","author":"Blaschke","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022040102575286100_b6","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1093\/cid\/cit578","article-title":"Better tests, better care: improved diagnostics for infectious diseases","volume":"57","author":"Caliendo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2022040102575286100_b7","first-page":"173","article-title":"Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis","volume":"41","author":"Jin","year":"2010","journal-title":"Labmedicine"},{"issue":"12","key":"2022040102575286100_b8","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1210\/en.2003-0854","article-title":"In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue","volume":"144","author":"Linscheid","year":"2003","journal-title":"Endocrinology"},{"issue":"6","key":"2022040102575286100_b9","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/en.2004-1424","article-title":"Autocrine\/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue","volume":"146","author":"Linscheid","year":"2005","journal-title":"Endocrinology"},{"issue":"3","key":"2022040102575286100_b10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.idc.2017.05.003","article-title":"Role of procalcitonin in the management of infected patients in the intensive care unit","volume":"31","author":"Gilbert","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"2022040102575286100_b11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/cid\/cix323","article-title":"Procalcitonin: the right answer but to which question?","volume":"65","author":"Bergin","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2022040102575286100_b12","doi-asserted-by":"crossref","first-page":"e2021052228","DOI":"10.1542\/peds.2021-052228","article-title":"Evaluation and management of well-appearing febrile infants 8 to 60 days old","volume":"148","author":"Pantell","year":"2021","journal-title":"Pediatrics"},{"key":"2022040102575286100_b13","unstructured":"American Pharmacists Association. FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis. Available at: https:\/\/www.pharmacist.com\/article\/fda-clears-test-help-manage-antibiotic- treatment-lower-respiratory-tract- infections-and. Accessed July 24, 2020"},{"key":"2022040102575286100_b14","unstructured":"Li\n              Q\n            \n          . Statistical considerations for procalcitonin-guided evaluation and management of lower respiratory tract infections and sepsis. Available at: https:\/\/fda.report\/media\/101238\/ Presentation-Statistical- Considerations-for-Procalcitonin- Guided-Evaluation-and-Management- of-Lower-Respiratory-Tract-Infections- and-Sepsis--of-the-Microbiology-Devices- Panel--Nov.-10--2.pdf. Accessed July 24, 2020"},{"key":"2022040102575286100_b15","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1007\/s001340051134","article-title":"Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock","volume":"26","author":"Brunkhorst","year":"2000","journal-title":"Intensive Care Med"},{"issue":"3","key":"2022040102575286100_b16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40121-019-0250-5","article-title":"Agreement between two procalcitonin assays in hospitalized children","volume":"8","author":"Katz","year":"2019","journal-title":"Infect Dis Ther"},{"issue":"12","key":"2022040102575286100_b17","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.rmed.2011.09.003","article-title":"Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia","volume":"105","author":"Esposito","year":"2011","journal-title":"Respir Med"},{"issue":"8","key":"2022040102575286100_b18","doi-asserted-by":"crossref","first-page":"e68419","DOI":"10.1371\/journal.pone.0068419","article-title":"Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial","volume":"8","author":"Baer","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"2022040102575286100_b19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s15010-015-0848-9","article-title":"The \u201cChoosing Wisely\u201d: initiative in infectious diseases","volume":"44","author":"Jung","year":"2016","journal-title":"Infection"},{"issue":"7","key":"2022040102575286100_b20","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"17","key":"2022040102575286100_b21","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010\u20132011","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"2022040102575286100_b22","first-page":"194","article-title":"Vital signs: improving antibiotic use among hospitalized patients","volume":"63","author":"Fridkin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2022040102575286100_b23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jpids\/piw091","article-title":"Procalcitonin accurately identifies hospitalized Children with low risk of bacterial community-acquired pneumonia","volume":"7","author":"Stockmann","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"4","key":"2022040102575286100_b24","doi-asserted-by":"crossref","first-page":"e20163231","DOI":"10.1542\/peds.2016-3231","article-title":"Impact of a National guideline on antibiotic selection for hospitalized pneumonia","volume":"139","author":"Williams","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"2022040102575286100_b25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1542\/peds.2014-3047","article-title":"Antibiotic choice for children hospitalized with pneumonia and adherence to national guidelines","volume":"136","author":"Williams","year":"2015","journal-title":"Pediatrics"},{"key":"2022040102575286100_b26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpeds.2020.10.005","article-title":"Antibiotic choice and clinical outcomes in ambulatory children with community-acquired pneumonia","volume":"229","author":"Lipsett","year":"2021","journal-title":"J Pediatr"},{"issue":"4","key":"2022040102575286100_b27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/INF.0000000000002986","article-title":"Use of a procalcitonin-guided antibiotic treatment algorithm in the pediatric intensive care unit","volume":"40","author":"Katz","year":"2021","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2022040102575286100_b28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2022040102575286100_b29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000477936","article-title":"Comparison of procalcitonin guidance-administered antibiotics with standard guidelines on antibiotic therapy in children with lower respiratory tract infections: A retrospective study in China","volume":"26","author":"Wu","year":"2017","journal-title":"Med Princ Pract"},{"issue":"5","key":"2022040102575286100_b30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.annemergmed.2015.02.003","article-title":"Impact of an electronic clinical decision support tool for emergency department patients with pneumonia","volume":"66","author":"Dean","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"17","key":"2022040102575286100_b31","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/jamainternmed.2013.8980","article-title":"Efficacy of an evidence-based clinical decision support in primary care practices: a randomized clinical trial","volume":"173","author":"McGinn","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"11","key":"2022040102575286100_b32","doi-asserted-by":"crossref","first-page":"e78602","DOI":"10.1371\/journal.pone.0078602","article-title":"Use of a computerized C-reactive protein (CRP) based sepsis evaluation in very low birth weight (VLBW) infants: a five-year experience","volume":"8","author":"Coggins","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"2022040102575286100_b33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/cid\/cix317","article-title":"Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia","volume":"65","author":"Self","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022040102575286100_b34","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1093\/cid\/cir050","article-title":"Procalcitonin as a biomarker in respiratory tract infection","volume":"52","author":"Gilbert","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/4\/384\/1275568\/hpeds.2021-006510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/4\/384\/1275568\/hpeds.2021-006510.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:59:44Z","timestamp":1648781984000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/12\/4\/384\/185415\/Association-Between-Procalcitonin-and-Antibiotics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,3,21]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2021-006510","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]}}}